Creative Medical Technology Holdings, Inc. General and Administrative Costs in Inventory, Amount Remaining
Creative Medical Technology Holdings, Inc. (CELZ) had General and Administrative Costs in Inventory, Amount Remaining of $29.75 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Notes
us-gaap:GeneralAndAdministrativeCostsInInventoryAmountRemaining · last filed 2025-11-07
- 2025-09-30: General and Administrative Costs in Inventory, Amount Remaining $29.75K.
| Period end | General and Administrative Costs in Inventory, Amount Remaining |
|---|---|
| 2025-09-30 | $29.75K 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |